Catalyst Wire Dossier Catalyst Wire Dossier

OGSIVEO

NIROGACESTAT · SpringWorks Therapeutics, Inc.
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for OGSIVEO, covering 2023-11-27 to 2026-08-20. Get the full timeline:

Most recent: FDA Approved: OGSIVEO — Supplemental Application (SpringWorks Therapeutics, Inc.)

See pricing